FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Owen Stephens

Research Profile

Disorders

Multiple Myeloma

Physiology

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Katie Stone; Susann M Szmania; Emily Woods; Bart Barlogie; Tarun K Garg; Brett Hall; Emily Hansen; Antje Hoering; Manjula Reddy; John D Shaughnessy; Owen Stephens; Frits van Rhee
Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels.
Yiming Zhou; Owen Stephens; Erming Tian; Qing Zhang; Bart Barlogie; Marie-Astrid Cartron-Mizeracki; Joshua Epstein; Christoph J Heuck; Jason Keller; Pingping Qu; Jeffrey R Sawyer; John D Shaughnessy
Prediction of cytogenetic abnormalities with gene expression profiles.
Owen Stephens; Erming Tian; David R Williams; Qing Zhang; Yiming Zhou; Bart Barlogie; Shweta Chavan; Joshua Epstein; Pingping Qu; John D Shaughnessy
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Owen Stephens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katie Stone; Susann M Szmania; Emily Woods; Bart Barlogie; Tarun K Garg; Brett Hall; Emily Hansen; Antje Hoering; Manjula Reddy; John D Shaughnessy; Owen Stephens; Frits van Rhee
Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels.
PloS one 2013;8(1):e54610.
2012: Yiming Zhou; Owen Stephens; Erming Tian; Qing Zhang; Bart Barlogie; Marie-Astrid Cartron-Mizeracki; Joshua Epstein; Christoph J Heuck; Jason Keller; Pingping Qu; Jeffrey R Sawyer; John D Shaughnessy
Prediction of cytogenetic abnormalities with gene expression profiles.
Blood 2012;119(21):e148-50.
2012: Owen Stephens; Erming Tian; David R Williams; Qing Zhang; Yiming Zhou; Bart Barlogie; Shweta Chavan; Joshua Epstein; Pingping Qu; John D Shaughnessy
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.
Blood 2012;119(2):503-12.
2011: John D Shaughnessy; Owen Stephens; Erming Tian; Saad Usmani; Frits van Rhee; Sarah Waheed; Ryan Williams; Qing Zhang; Yiming Zhou; John Crowley; Joshua Epstein; Ichiro Hanamura; Christoph J Heuck; Bijay Nair; Pingping Qu; Yazan Alsayed; Elias Anaissie; Bart Barlogie
Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.
Blood 2011;118(13):3512-24.
2010: Yiming Zhou; Lijuan Chen; Bart Barlogie; Owen Stephens; Xiaosong Wu; David R Williams; Marie-Astrid Cartron; Frits van Rhee; Bijay Nair; Sarah Waheed; Mauricio Pineda-Roman; Yazan Alsayed; Elias Anaissie; John D Shaughnessy
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(17):7904-9.
2008: Ya-Wei Qiang; Yu Chen; Owen Stephens; Nathan Brown; Bangzheng Chen; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
Blood 2008;112(1):196-207.
2007: Christina Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Cancer cell 2007;12(2):115-30.
2007: Simona Colla; Fenghuang Zhan; Wei Xiong; Xiaosong Wu; Hongwei Xu; Owen Stephens; Shmuel Yaccoby; Joshua Epstein; Bart Barlogie; John D Shaughnessy
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.
Blood 2007;109(10):4470-7.
2006: Daniel R Carrasco; Giovanni Tonon; Yongsheng Huang; Yunyu Zhang; Raktim Sinha; Bin Feng; James P Stewart; Fenghuang Zhan; Deepak Khatry; Marina Protopopova; Alexei Protopopov; Kumar Sukhdeo; Ichiro Hanamura; Owen Stephens; Bart Barlogie; Kenneth C Anderson; Lynda Chin; John D Shaughnessy; Cameron Brennan; Ronald A DePinho
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.
Cancer cell 2006;9(4):313-25.